COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

long covid brainstem damage

Ultra-high field MRI implicates long COVID in brainstem damage

Researchers have used 7T MRI to demonstrate that former COVID-19 inpatients are susceptible to persistent brainstem abnormalities associated with long-haul COVID symptoms.

Monitoring acute heart patients at home linked to considerable cost savings

The new report could go on to help guide decisions made by CMS and hospital leadership teams for years to come.

Thumbnail

MRI study pinpoints neural roots of lingering fatigue post-COVID infection

Some of the findings observed have also been reported in patients who have multiple sclerosis, “which could suggest partially shared pathophysiological substrates of fatigue symptoms,” researchers indicated. 

Thumbnail

MRI findings linked to cognitive issues in patients with long COVID 2 years post-infection

The CDC estimates that just under 7% of adults in the United States continue to struggle with symptoms of long COVID.

Nemours Children's Hospital pediatric cardiologists explain lessons learned about cardiac involvement and long-term issues from multisystem inflammatory syndrome in children (MIS-C), a rare but serious disease caused by exposure to the COVID-19 virus. #MIS-C #COVID #coronavirus #SARSCoV2

A key update on how COVID-19 caused dangerous MIS-C inflammation in children

The rise of MIS-C during the COVID-19 pandemic alarmed physicians and patients alike, and the exact cause was unclear. Now, new NIH-funded research appears to provide some answers.

COVID-19 coronavirus mask smell

Loss of smell during COVID linked to structural, functional brain alterations

According to data shared by the CDC last year, around 34% of patients who contracted COVID between 2020 and 2023 reported losing their sense of smell. 

phenylephrine FDA

COVID remnants still show up on PET/CT scans years after infection

That’s according to new PET imaging that shows the presence of activated T cells in the brain, spinal cord, gut and lung tissues of individuals who have recovered from COVID.

Imaging study reveals 'significant deformities' in lungs of some COVID patients

These changes could have long-lasting implications for lung function, authors of the new study warn.